Company intelligence / Profile preview

Fiflow

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

FiFlow is a medical technology company specializing in the development of innovative interventional devices for structural heart disease and vascular interventions. The company focuses on transcatheter solutions, including mitral valve repair and replacement systems, as well as aortic valve therapies. FiFlow aims to provide minimally invasive alternatives to traditional open-heart surgeries, leveraging advanced engineering to improve patient outcomes in cardiology. Based in Hangzhou, China, the company is actively advancing its product pipeline through clinical trials and regulatory pathways.

Therapeutic areas: Cardiovascular
Modalities: DeviceInterventional Cardiology Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Fiflow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fiflow.

Explore the full profile